logo
Why we can't squash the common cold, even after 100 years of studying it

Why we can't squash the common cold, even after 100 years of studying it

Yahoo06-04-2025
Before germs were first spied under a microscope by Robert Koch, a doctor from East Prussia, catching colds was blamed on evil spirits, foul weather, and medical enigmas such as blood impurities. Koch's findings ignited the medical community in the late 19th century. Many of humanity's dreaded afflictions soon had microbial faces of a sort and, more importantly, specific organisms for doctors and scientists to study: The cause of tuberculosis was identified in 1882, cholera in 1883, salmonella and diphtheria in 1884, pneumonia in 1886, and tetanus in 1889. In 1883, Popular Science was among the first publications to forward and promote the emerging and controversial germ theory of disease. Even as some in the medical community resisted mounting evidence for germ theory, the 1880s became known as the golden age of bacteriology. In that same decade, Louis Pasteur, a French chemist, developed the first human vaccine, which successfully prevented rabies in a single-person trial.
But folklore is stubborn, capable of resisting even the most compelling facts. By 1925, when Popular Science reported the findings of the US Public Health Service's first-ever survey on the common cold, many still clung to outdated beliefs despite four decades of germ science.
As contributing writer Malcolm MacDonald noted, the myth persisted that colds were typically caused by 'bad weather or wet feet.' MacDonald pressed the case for germs as the root cause of the common cold, even though no specific pathogen had yet been identified in 1925. 'The common cold, at least some varieties, is extremely contagious,' MacDonald wrote. 'Prevention lies in avoiding contact with sufferers.' We've learned much about the common cold since 1925—from its underlying viruses to its seasonality. But we still contract it just as frequently as we did a century ago; we still suffer the same symptoms for the same duration; and there's still no vaccine. In other words, 'avoiding contact with sufferers' remains the best prevention even after a hundred years.
It wasn't until the 1950s that the common cold's elusive origins began to surface. Inspired by the success of Jonas Salk's polio vaccine, some researchers set their sights on curing the common cold. But, as Popular Science reported in November 1955, scientists were playing catch-up. It wasn't clear which viruses caused the common cold, or how many there might be. Robert Huebner, a US Public Health Service virologist, had identified adenovirus in 1953 as a contributor, but it soon became clear that adenovirus was not the only one. By 1956, Winston Price, a Johns Hopkins University virologist, had discovered rhinovirus as another cause. Since then, three species of rhinovirus have been identified (A, B, and C).
The more scientists dug into the common cold, the more they learned that what we thought of as the common cold was just a catch-all for similar upper respiratory symptoms caused by several different viruses, amounting to hundreds of different strains. While rhinoviruses account for as much as 30–50 percent of common cold cases, and non-Covid coronaviruses another 10–15 percent, other causes include adenoviruses, respiratory syncytial viruses (RSV), and parainfluenza (non-flu) viruses.
Although there are more than a billion cases of the common cold in the US each year—two to four cases on average for each adult, more for children—there has been little progress on a vaccine because of the sheer number of viral strains such a vaccine would need to target. Fortunately, an RSV vaccine is now available for vulnerable populations like infants and the elderly. But RSV only accounts for a fraction of common cold cases. Even a rhinovirus vaccine, which would require more than 100 strains in one dose, would not prevent a majority of cases.
While a universal common cold vaccine remains elusive, many of MacDonald's century-old observations about prevention, treatment, and seasonality have stood the test of time. They remain uncannily accurate considering the root cause of the common cold had not yet been identified in 1925. For instance, MacDonald went to great lengths to explain how stifling indoor conditions during the winter months could make us susceptible to colds, writing: 'This hot dry air is very irritating to the nerves and injurious to the eyes. It makes the membranes of the nose and throat too dry, which is harmful.' MacDonald was onto something. We now know that while weather is not a direct cause of colds, our environment matters. Dry air—hot or cold—can reduce mucosal defenses, making people more susceptible to infections. We also know that common cold viruses are highly contagious and spread more easily indoors than outdoors through airborne droplets, direct contact, and contaminated surfaces. Fortunately, 21st-century indoor environments tend to be a bit more sanitary than in MacDonald's day, with improved ventilation systems and air purifiers.
MacDonald also cited the US Public Health Service's observation about the seasonality of common colds, with the largest peak in October and another smaller peak in January. Similar peaks still exist, especially in northern regions, although they move around a bit. Today, just as in 1925, seasonal peaks are often connected with the resumption of the school year (an October, or autumn, peak) and holiday gatherings (January), when people tend to gather indoors.
MacDonald even described certain risk factors for catching colds. He claimed that 'colds are most apt to attack overfed, under-exercised and constipated people, and those who avoid fresh air.' Our 21st-century understanding of risk factors is a bit more nuanced. Being 'overfed, under-exercised and constipated' are only risk factors if they represent psychological stress, which lowers immune response to any infection. Similarly, lack of sleep, age, and smoking are risk factors as well as autoimmune disorders and other diseases.
As for treating a common cold, MacDonald recommended a 'hot full-tub bath' at the onset of symptoms, immediately followed by one to three days of rest 'in a fairly well-ventilated room.' He also suggested the 'right diet,' including 'fruit and fresh vegetables and not too much meat or pastry.' According to the 1925 US Public Health Service survey, when such measures were taken, the 'average length of disability for all respiratory disorders is slightly less than 6 ½ days.' MacDonald cautioned that not taking such measures could lead to much more serious conditions. His treatment recommendations and warnings still track with the advice offered by 21st-century clinics, like Johns Hopkins Medicine, which includes getting rest, drinking fluids, eating well, and using indoor vaporizers. Today, we have decongestants and pain relievers that were not available in 1925, but there is still no cure, and the duration of a cold is about the same—several days to a couple weeks.
More than anything, MacDonald's article highlights how the 1925 US Public Health Service survey represented an early scientific approach—a first—to understanding common colds, gathering population-level data rather than anecdotal evidence. Building on that science for a century has given us the tools to better understand colds—to know what causes them, how to prevent them, how to treat them, and what the risk factors are for more serious illness. Despite all this knowledge, the best advice in 2025 isn't dramatically different from 1925: Avoid contact with sufferers, rest, and maintain healthy habits. We may not have a universal vaccine, but if we stick to the science, even that may be within reach—hopefully long before the next centennial of MacDonald's groundbreaking article.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Contributors to Scientific American 's September 2025 Issue
Contributors to Scientific American 's September 2025 Issue

Scientific American

time8 hours ago

  • Scientific American

Contributors to Scientific American 's September 2025 Issue

David Cheney Brain Washing David Cheney is no mere artist—he's a board-certified medical illustrator. In the Johns Hopkins University program where Cheney got his master's degree, the artists study right alongside the medical students. So when Scientific American asked Cheney to render cerebrospinal fluid entering and exiting the brain for a feature by journalist Lydia Denworth on how the organ cleans waste during sleep, he already had a strong understanding of the anatomy. Cheney filled stacks of sketchbooks as a kid but assumed he'd end up premed in college. He experimented with different paths (for a time, he was a musical theater major) until he learned about a career in medical illustration. It was an instant and lasting fit. 'The field might be niche,' he says, 'but it's so varied in terms of what you can do with the training.' On supporting science journalism If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today. He's worked for medical clinics, academic institutions, and even a tech startup where he's designing 'an entire race of aliens' for a cryptocurrency game. Cheney would like to do more sculpture, specifically reconstructing 'some extinct type of creature' for a natural history museum. 'I wish more young artists who love science knew about this field where you can truly use both sides of your brain.' Dava Sobel Meter When writer Dava Sobel learned that the earliest issues of Scientific American included poetry, she wanted to bring that tradition back to the magazine. Her pitch was to publish existing poems about science; instead the editors tasked her with soliciting original work. Sobel first approached poets she knew—Diane Ackerman was the inaugural contributor to the Meter column in January 2020—and then 'the flood began,' she says. 'The backlog of submissions is now yearslong.' Sobel doesn't write poetry herself, but her long career as a science journalist and author has often involved 'unearthing people's letters, showing scientists as the real people they are.' Her first big success, she says, was her 1995 book Longitude, 'which allowed me to write all the others.' One of the best fun facts about Sobel is she served on the Planet Definition Committee that redefined the term in 2006—an endeavor that ultimately led to Pluto losing its status as a planet. That move 'was not our recommendation!' As the Meter editor, Sobel looks for poems that 'cause an emotional leap in me.' Other times she'll choose a poem because 'it attempts a tremendous challenge—and works.' Meter hopefuls take note: Sobel has a limit on limericks but likes to publish at least one humorous poem every year. 'I'm the first to admit it's totally subjective, and contributors are totally at my mercy.' Charles C. Mann Research in Reverse When we asked author Charles C. Mann to write an essay about dramatic twists and turns in science, Mann, fortuitously, was already mulling the subject. 'I write to try to figure out what I think,' he says. He teased apart genuine 180s— 'when assumptions baked into a discipline turn out not to be right after someone gives them a hard look'—from a fraught kind of pivot, 'when the normal back-and-forth of science gets pinned by people who make definitive proclamations based on exaggerated evidence.' For someone who wrote a book (entitled 1491) that rethinks the environmental history of an entire continent, Mann isn't sure he's any better at coping with uncertainty than the rest of us. 'But I would say I'm comfortable admitting that chance plays a huge role in what happens to me.' Sometimes, while working on a project, he gets 'distracted by worrying about if I actually know what I'm talking about.' The research discursions that follow often lead to satisfying revelations. 'It's good to be aware of one's own fallibility,' he says. Mann has seemingly lost track of how many books he's written ('I don't know, nine?'), but his next one, about the North American West, will be published in 2026. Andrew B. Myers Peanut Proof Photographer Andrew B. Myers (above), who shot this month's cover story on peanut allergies by writer Maryn McKenna, likes the constraint of creating big worlds at small scale. What did Myers seek in the ideal peanut model? 'You look for the very basic quality of a peanut, this eight shape with an hourglass curve,' he says. 'But the curve can't be so basic it looks fake. You want 90 percent perfect peanut and 10 percent little quirk. Just like human attractiveness.' By giving his subject a halolike light, Myers sought to make a singular, tiny peanut 'feel ridiculously heroic.' Manipulating peanut butter for the shoot was less satisfying. 'It's kind of a gross, difficult substance to work with.' Myers takes a layered and 'zany' approach to making still-life images and describes himself as more of a sculptor and designer than a photographer. 'I care a lot about building the frame and mixing processes,' he says. 'I make things in a controlled, quiet setting with a camera on a tripod. I can't remember the last time I held a camera in my hands.' Myers, who has worked for a range of editorial and commercial clients, has an affinity for shooting scientific concepts in a clever, unexpected way. He's inspired by the imagery that comes out of the lab of his spouse, who is a computational neuroscientist. 'I like when scientists and artists get together,' he says. 'Scientists are much more humble than your average artist, but both look outward and have a rock of curiosity.'

The Epilepsy Foundation of America Launches AI Assistant to Transform Support for Epilepsy Community, Powered by Amazon Web Services
The Epilepsy Foundation of America Launches AI Assistant to Transform Support for Epilepsy Community, Powered by Amazon Web Services

Yahoo

timea day ago

  • Yahoo

The Epilepsy Foundation of America Launches AI Assistant to Transform Support for Epilepsy Community, Powered by Amazon Web Services

The new AI-Assistant, Sage, will build on the Foundation's ability to connect with the 3.4 million people living with epilepsy in the United States, increasing access to support and information BOWIE, Md., Aug. 18, 2025 /PRNewswire/ -- The Epilepsy Foundation of America (EFA) has announced the launch of its revolutionary AI Assistant, Sage. Developed in partnership with Amazon Web Services (AWS) and powered by Anthropic's Claude, this AI Assistant is one of the most empathetic AI systems ever created. Sage was made as a result of a transformative five-year digital journey and is now available for all to use on Sage is a purpose-built, intelligent, and emotionally aware companion trained on the lived experiences of the epilepsy community and infused with authoritative medical knowledge from a digital archive of over 25,000 curated pages of comprehensive epilepsy information and resources dating back to 2002. It is engineered to answer questions, understand context, track conversations across time, recognize emotional nuance, and deliver clear, accurate, and compassionate guidance instantly. Sage can also answer questions in multiple languages, including English, Spanish, French, Portuguese, and German. "This new technology is an extension of the Foundation's mission to ensure that no one faces epilepsy alone," said David Jost, Chief Technology Innovations Officer, Epilepsy Foundation of America. "Sage will be available at any time, in any place, to any member of the community. It learns from the context of previous inquiries, adapts to ongoing needs, and provides continuity of care in a digital environment." Whether you are navigating a new diagnosis, seeking guidance for a child, learning more about epilepsy treatments, or looking for ways to support a loved one, Sage is here and focused on your well-being. "With the help of Amazon Web Services, we built both a tool and companion," said Bernice Martin Lee, Chief Executive Officer, Epilepsy Foundation of America. "A tool that embodies the experience of our community, the brilliance of our clinical experts, and the power of AI. This assistant represents our promise that no one should ever have to face epilepsy alone." Built on Amazon Bedrock, Sage does what search engines cannot. It supersedes open-ended online queries, bypassing the noise and confusion to deliver the most relevant, accurate, and trustworthy information in seconds. Its responses are grounded in clinical expertise, community experience, and a deep understanding of what it means to live with epilepsy. "We are honored to support the Epilepsy Foundation of America in delivering a solution that brings reliable, accessible, and compassionate support to individuals and families affected by epilepsy," said Jeff Kratz, Vice President of Nonprofits and Worldwide Public Sector Industries at Amazon Web Services. "It has been deeply rewarding to work alongside such a mission-driven organization, and we are excited to see this powerful technology provide real value to the epilepsy community. This launch reflects the best of what is possible when purpose-led innovation meets cutting-edge cloud capabilities." This new tool does not replace the Epilepsy Foundation's ongoing human interaction. The Epilepsy Helpline, staffed by EFA employees, will continue to be available from 8 a.m. to 8 p.m. ET starting on August 25, 2025 for additional questions and connection. Sage is now ready on to support anyone. The Foundation encourages you to explore this new resource. We want to meet you where you are on your journey. We invite you to experience how this technology can simplify answers to your questions whenever you need it. About EpilepsyEpilepsy is the most common chronic brain disorder in the world, affecting people of all ages, races, and backgrounds. According to the U.S. Centers for Disease Control and Prevention (CDC), nearly 3.4 million Americans live with active epilepsy. The condition is defined by a tendency to experience seizures—sudden, abnormal bursts of electrical activity in the brain that can disrupt behavior, awareness, and bodily control. Beyond seizures, epilepsy can also lead to challenges such as fatigue, memory difficulties, mood changes, anxiety, and trouble concentrating, all of which can significantly impact daily life. Visit to learn more. About the Epilepsy Foundation of AmericaThe Epilepsy Foundation America is a national nonprofit organization dedicated to improving the lives of people affected by epilepsy through education, advocacy, research, and connection. For more than 50 years, the Foundation has led efforts to raise awareness, reduce stigma, and advocate for policies that make a meaningful difference for individuals living with epilepsy. We also fund cutting-edge research and support early-career investigators working to discover new treatments and therapies. Through our nationwide network of local offices and community partners, the Foundation expands access to care, provides seizure recognition and first aid training, and delivers direct services to those in need. To learn more visit or call 1.800.332.1000; in Spanish or call 866.748.8008. About Amazon Web ServicesSince 2006, Amazon Web Services has been the world's most comprehensive and broadly adopted cloud. AWS has been continually expanding its services to support virtually any workload, and it now has more than 240 fully featured services for compute, storage, databases, networking, analytics, machine learning and artificial intelligence (AI), Internet of Things (IoT), mobile, security, hybrid, media, and application development, deployment, and management from 117 Availability Zones within 37 geographic regions, with announced plans for 13 more Availability Zones and four more AWS Regions in Chile, New Zealand, the Kingdom of Saudi Arabia, and the AWS European Sovereign Cloud. Millions of customers—including the fastest-growing startups, largest enterprises, and leading government agencies—trust AWS to power their infrastructure, become more agile, and lower costs. To learn more about AWS, visit View original content to download multimedia: SOURCE Epilepsy Foundation Sign in to access your portfolio

Man who went blind after drinking alcohol in Laos now raising awareness
Man who went blind after drinking alcohol in Laos now raising awareness

Yahoo

timea day ago

  • Yahoo

Man who went blind after drinking alcohol in Laos now raising awareness

A man who went blind after drinking alcohol in Laos is working with other affected families to campaign for awareness of methanol poisoning. Calum Macdonald had a night out in Vang Vieng in November last year and the next day his vision was 'engulfed in this blinding white light', he told BBC Breakfast. Police in Laos have previously detained several people in connection with the deaths of six people who are believed to have been poisoned, including Simone White, 28, from Orpington, Kent. Methanol is sometimes used by disreputable bars as a cheaper alternative to ethanol but can cause severe poisoning or death. Mr Macdonald was at a hostel where free whisky and vodka shots were offered, and he mixed them with soft drinks, he said. He told how he was on a bus crossing into Vietnam when he noticed something was wrong. He told BBC Breakfast: 'The point at which I really started to notice some strange side effects was we briefly got off the bus to cross the border into Vietnam, and we went through the border office – we had to fill out a number of forms to get across to the other side – and at that point, sort of my entire vision was engulfed in this blinding white light. 'And I just thought, you know, this is very strange. I couldn't actually see where I was walking.' He added: 'We arrived in Hanoi, and at that point, the kind of white light in my eyes had diminished, and it wasn't until we got to our hotel room and my friends and I were sitting in the room, and I said to my friends, why are we sitting in the dark here? Let's turn on a light. And they informed me that the light was, in fact, already on.' Mr Macdonald then went to hospital and said on the journey there he 'really started to struggle to breathe' and could 'barely get my words out'. He said a number of tests were carried out initially but it was not until he got back to England when he was in hospital and they 'really sort of indicated that it was definitely related to something I'd been drinking'. Mr Macdonald is now speaking out as he wants information to be available to people about methanol poisoning, especially students who might be preparing to go on a gap year. He said: 'I think I definitely feel a sense of responsibility as someone who's been lucky enough to survive this, to try and get the message out. Because I know certainly, if I'd known about it, I wouldn't be in this situation. 'And I know I have a lot of friends that have also done similar sort of gap years in travelling around even that particular area. And so definitely, I think it's quite important. 'I've had the opportunity to speak to a number of other families that have been affected by this, and they're far more knowledgeable and have been campaigning for awareness for a lot longer than I have been involved. And what they tend to say generally is that sometimes the advice isn't put in strong enough terms. 'And so I think, I guess if I was to put out a recommendation to people, although I'm certainly not an expert or a medical professional, I would probably say that if you did want to drink alcohol in some of the affected countries, probably just to avoid spirits entirely. 'I think it would be nice, even if we could get some more information directly into universities, because I think that's the age of people that are really considering doing these kinds of trips, I think that would be a great thing.' The Foreign, Commonwealth and Development Office has been approached to comment.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store